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Recent advances in the clinical virology ofinfluenza are based on non-pragmatically oriented
research on the genetics and biochemistry of the influenza virus. Antigenically hybrid recombi-
nant viruses can be tailored to provide monospecific reagents for serological studies. Basic
research on viral structure and the mechanism of viral replication has directly influenced the
establishment of a cell culture system suitable for the isolation of most influenza viruses.
Identification of viral genotype by RNA gel electrophoresis and mapping ofoligonucleotides of
viral RNA has already facilitated epidemiologic investigations. The clinical virologist of the
future must have an understanding of the potential limitations of these techniques for specific
strain identification.
Rather than review the well established and well known procedures employed in
the isolation and identification of influenza viruses, I should like to take this
opportunity to describe some recent developments in basic research on these viruses
that have already had practical application to clinical diagnosis. In addition, I shall
suggest some implications for the future ofclinical virology ofcurrent research on the
molecular genetics of influenza viruses.
THE USE OF PROTEASES IN INFLUENZA VIRUS-HOST CELL SYSTEMS-
A NEW STRATAGEM FOR VIRAL ISOLATION
The isolation of influenza viruses until recently has required the use of embryo-
nated eggs or primary or secondary monkey kidney cell culture-systems not readily
available in many laboratories. Other primary cell systems have been cumbersome
and have not received wide acceptance. Theaneuploid cell lines so convenient for the
isolation of other human viruses do not support the replication ofinfluenza viruses in
general [1]. The first aneuploid cell found to be permissive for influenza virus
replication, the Wong-Kilbourne mutant of the Chang conjunctival cell line [2,3] was
relatively insusceptible to many influenza viruses. A neglected paper by Gaush and
Smith in 1968 [4] described plaque formation by a number of influenza A and B
viruses in a canine kidney cell line (MDCK) established by Madin and Darby [5].
Despite this discovery of a relatively permissive cell system, MDCK cells proved
variable in sensitivity to many viral strains.
The final solution to the problem came from a combination of empirical observa-
tion and basic studies of viral structure and function. The incorporation oftrypsin in
overlay media had been found to enhance influenza virus plaque formation by an
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undefined mechanism [6-9]. Unrelated studies of viral structure demonstrated that
endogenous cleavage of the viral hemagglutinin by endogenous proteases in the
infected host cell was required for optimal infectivity of the virus particle [10,11].
Furthermore, addition of exogenous trypsin to virus with uncleaved hemagglutinin
resulted in increased infectivity of such preparations [12]. It is now clear that the
enhancing effect of trypsin on plaque formation is the result of its action on the
hemagglutinin of the budding virus-not on the cell per se. Thus, when MDCK cells,
the most permissive of cells available, are overlaid with trypsin-containing media, a
highly permissive and sensitive host cell system is available for the cultivation and
primary isolation of influenza viruses [13]. Recent studies have shown that the
MDCK cell-trypsin system may be more sensitive than either eggs or Rhesus monkey
cells for isolation of currently circulating influenza A and B strains. Sufficient
hemagglutinin was produced on the initial tissue culture passage to allow direct
identification of isolates by hemagglutination-inhibition tests. The same study
demonstrated that a variety of other respiratory viruses also replicated in MDCK
cells so that over a ten-month period 35 percent of600 specimens yielded virus in this
system [14].
I have detailed the development of this virus isolation system only to make what I
think is an important and perhaps neglected point. That is, the importance of
modifying environmental and cultural conditions as well as cell type before conclud-
ing that presently available cells are insusceptible to viruses. Although intrinsic
cellular susceptibility is indeed important (even with the MDCK cell-trypsin system)
the implication of the trypsin story is that other appropriate manipulations of
cultural conditions (changes in pH, incubation temperature, etc.) should be explored,
in addition to searching for new cell types. Furthermore, the annoying variability in
susceptibility encountered with cells already used in viral diagnostic work can be
addressed by cloning of these ordinarily heterogeneous cell populations [2].
THE USE OF RECOMBINANT VIRUSES IN CLINICAL VIROLOGY
Influenza viruses possessingsegmented RNA genomes readily undergo recombina-
tion during coinfection of cells in the laboratory with different strains of the same
type [15]. By the use of appropriate selective systems, new viruses with the required
characteristics that are uniquely suited for serologic studies can be isolated. Thus,
antigenic hybrids can be engineered to possess the hemagglutinin (HA) antigen ofone
parental virus and the neuraminidase (NA) of the other [16,17]. Such recombinants
are effectively monospecific antigenically when used in measurement of antibody
response to virus identical to one or the other parent. For example, the level ofanti-
hemagglutinin antibody to the H1 antigen following infection with H1N1 influenza
virus (the currently circulating subtype) is most accurately determined using a
recombinant virus that does not bear an NI neuraminidase (NA) antigen (e.g., HIN2)
and hence is not sterically inhibited by the combined effects of anti-hemagglutinin
and anti-neuraminidase antibody. Antibody rises so demonstrated may be lesser in
magnitude but will be more specific. The great change in the HA antigen (from H2 to
H3) in 1968 was not immediately appreciated because the new Hong Kong virus
(H3N2) possessed the same (N2) NA antigen as the antecedent Asian (H2N2) strain.
Antibodies to H2N2 virus were cross-reactive with H3N2 through the common NA
antigen and obscured the magnitude ofantigenic differences between the H2 and H3
hemagglutinin components. When antisera monospecific for the hemagglutinin were
prepared with antigenic hybrids in which H2 hemagglutinin was segregated from the
N2 NA [18] it became clear that the new Hong Kong virus was essentially a
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composite of an "old" NA and a "new" HA and therefore a possible natural
recombinant [19]. Epidemiologic considerations aside, diagnosis of the individual
case and identification of viruses during the past decade of HK prevalence has been
facilitated by the use of HA-specific and NA-specific reagents-now routinely
provided by the CDC and WHO. NA-specific antigenic hybrids have also been
employed in vaccines to induce NA-specific immunity [20,21,22].
POTENTIAL CONTRIBUTION TO THE MOLECULAR
EPIDEMIOLOGY OF INFLUENZA VIRUSES BY
THE BIOCHEMICAL CHARACTERIZATION
OF INFLUENZA VIRUS GENES
In 1973, I used the term "molecular epidemiology" [23] to review the contribution
of more precise antigenic and biochemical characterization of influenza viruses to an
understanding of their epidemiology. As mentioned earlier, the recognition of the
Hong Kong (H3N2) pandemic virus as more thanjust another"A2" strain came from
such analysis.
Since that time, a technique had been developed that permits the definition of
distinctive patterns of extracted viral RNAs on polyacrylamide gel electrophero-
grams and makes possible comparisons among viruses with respect to all 8 genes of
the virus [24,25]. This method demonstrated that the virus isolated from the 1976
epidemic of influenza at Fort Dix was indistinguishable from contemporary swine
influenza virus strains and therefore had most likely originated from swine [26].
Although this method will continue to be useful in comparisons and categorization of
new isolates, it usually is inadequate to pick up single or point mutations that may be
critical in determining the virulence or transmissibility of a virus, unless such base
changes affect secondary RNA structure and therefore migration patterns on gels. A
case in point is two swine influenza virus hemagglutinin mutants which have identical
RNA gel patterns but marked differences in biological properties, probably deter-
mined by a single mutation [27].
The further refinement of oligonucleotide mapping of T-1 ribonuclease digests of
influenza viral RNAs offers promise for much more precise strain identification
[28,29]. This technique already has revealed a startling similarity of the new Russian
HlNl virus to a 1950 strain with respect to all genes-not just those coding for the
surface glycoproteins.
Although hardly applicable to the diagnostic laboratory at present, in the manner
of salmonella typing, these refinements ofviral technology offer promise ofdefinitive
strain identification, perhaps by WHO, state, or medical center laboratories in the
future. In related studies, the fingerprinting of herpes simplex virus strains by using
restriction endonucleases originally devised for mapping of the viral DNA has
already contributed to the tracing oftransmission of HSV in a new-born nursery [30]
and may solve legal questions concerning the source of genital infections [31].
No longer is the clinical virologist content to identify an isolate merely as influenza
A, B, or C. In the future he will contribute to the identification ofregionally or locally
prevalent strains of virus and will participate therefore even more than in the past in
defining influenza viral epidemiology and disease patterns.
NOTE ADDED IN PROOF
Oligonucleotide mapping ofrecent 1978-79 influenza Aviruses has shown that one
such virus prevalent in the United States is a natural recombinant of HlNl and
H3N2 viruses that co-circulated in man the previous year [32].
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